BBA
NGM
Baker Bros. Advisors’s NGM Biopharmaceuticals, Inc. Common Stock NGM Stock Holding History
| Quarter | Market Value | Status | Shares |
Shares Change % | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2022
Q3 | – | Sell |
-55,294
| Closed | -$709K | – | 125 |
|
|
2022
Q2 | $709K | Sell |
55,294
-236,507
| -81% | -$3.03M | ﹤0.01% | 103 |
|
|
2022
Q1 | $4.45M | Hold |
291,801
| – | – | 0.03% | 88 |
|
|
2021
Q4 | $5.17M | Hold |
291,801
| – | – | 0.03% | 93 |
|
|
2021
Q3 | $6.13M | Hold |
291,801
| – | – | 0.03% | 88 |
|
|
2021
Q2 | $5.75M | Hold |
291,801
| – | – | 0.03% | 93 |
|
|
2021
Q1 | $8.48M | Buy |
291,801
+185,185
| +174% | +$5.38M | 0.04% | 81 |
|
|
2020
Q4 | $3.23M | Sell |
106,616
-11,484
| -10% | -$348K | 0.01% | 103 |
|
|
2020
Q3 | $1.88M | Sell |
118,100
-6,300
| -5% | -$100K | 0.01% | 103 |
|
|
2020
Q2 | $2.46M | Sell |
124,400
-125,600
| -50% | -$2.48M | 0.01% | 97 |
|
|
2020
Q1 | $3.08M | Hold |
250,000
| – | – | 0.02% | 78 |
|
|
2019
Q4 | $4.62M | Hold |
250,000
| – | – | 0.02% | 72 |
|
|
2019
Q3 | $3.46M | Hold |
250,000
| – | – | 0.02% | 72 |
|
|
2019
Q2 | $3.66M | Buy |
+250,000
| New | +$3.66M | 0.02% | 68 |
|